Guided Therapeutics, Inc.
GTHP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $8,601 | $7,849 | $9,752 | $7,759 |
| - Cash | $388 | $591 | $2,313 | $643 |
| + Debt | $2,159 | $2,058 | $2,263 | $2,899 |
| Enterprise Value | $10,372 | $9,316 | $9,702 | $10,015 |
| Revenue | $7 | $98 | $13 | $81 |
| % Growth | -92.9% | 653.8% | -84% | – |
| Gross Profit | $2 | $36 | -$68 | $20 |
| % Margin | 28.6% | 36.7% | -523.1% | 24.7% |
| EBITDA | -$1,941 | -$3,126 | -$3,687 | -$919 |
| % Margin | -27,728.6% | -3,189.8% | -28,361.5% | -1,134.6% |
| Net Income | -$2,417 | -$3,489 | -$4,341 | -$2,070 |
| % Margin | -34,528.6% | -3,560.2% | -33,392.3% | -2,555.6% |
| EPS Diluted | -0.045 | -0.074 | -0.15 | -0.18 |
| % Growth | 38.5% | 51% | 16.7% | – |
| Operating Cash Flow | -$1,119 | -$1,746 | -$1,478 | -$1,592 |
| Capital Expenditures | $0 | $0 | -$31 | -$14 |
| Free Cash Flow | -$1,119 | -$1,746 | -$1,509 | -$1,606 |